Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004;363(9420):1535–43. https://doi.org/10.1016/S0140-6736(04)16153-9.
Article
PubMed
Google Scholar
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neuro-Oncol. 2010;99(3):307–14. https://doi.org/10.1007/s11060-010-0386-3.
Article
Google Scholar
Li X, Zhao J. Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up. Childs Nerv Syst. 2009;25(11):1411–7. https://doi.org/10.1007/s00381-009-0949-9.
Article
PubMed
Google Scholar
Menon G, Nair S, Sudhir J, Rao B, Mathew A, Bahuleyan B. Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir. 2009;151(3):239–44. https://doi.org/10.1007/s00701-009-0206-8.
Article
CAS
PubMed
Google Scholar
Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20. https://doi.org/10.1007/s00401-016-1545-1.
Article
PubMed
Google Scholar
Saydam O, Erkan EP, Strobel T, Dorfer C, Sontagbauer M, Weinhaeusel A, et al. Circulating tumor biomarkers in meningiomas reveal a signature of equilibrium between tumor growth and immune modulation. Front Oncol. 2019;9:1031.
Article
Google Scholar
Lassalle P, Molet S, Janin A, Van der Heyden J, Tavernier J, Fiers W, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271(34):20458–64. https://doi.org/10.1074/jbc.271.34.20458.
Article
CAS
PubMed
Google Scholar
Palmiere C, Augsburger M. Endocan measurement for the postmortem diagnosis of sepsis. Leg Med (Tokyo). 2014;16(1):1–7. https://doi.org/10.1016/j.legalmed.2013.09.007.
Article
CAS
Google Scholar
Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta Rev Cancer. 2006;1765(1):25–37. https://doi.org/10.1016/j.bbcan.2005.08.004.
Article
CAS
Google Scholar
Yang J, Yang Q, Yu S, Zhang X. Endocan: a new marker for cancer and a target for cancer therapy. Biomed Rep. 2015;3(3):279–83. https://doi.org/10.3892/br.2015.438.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scherpereel A, Gentina T, Grigoriu B, Sénéchal S, Janin A, Tsicopoulos A, et al. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63(18):6084–9.
CAS
PubMed
Google Scholar
Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006;34(2):532–7. https://doi.org/10.1097/01.CCM.0000198525.82124.74.
Article
CAS
PubMed
Google Scholar
Caires NDF, Gaudet A, Portier L, Tsicopoulos A, Mathieu D, Lassalle P. Endocan, sepsis, pneumonia, and acute respiratory distress syndrome. Crit Care. 2018;22(1):280. https://doi.org/10.1186/s13054-018-2222-7.
Article
Google Scholar
Béchard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001;167(6):3099–106. https://doi.org/10.4049/jimmunol.167.6.3099.
Article
PubMed
Google Scholar
Ustyol A, Aycan Ustyol E, Gurdol F, Kokali F, Bekpınar S. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease. Scand J Clin Lab Invest. 2017;77(3):205–9. https://doi.org/10.1080/00365513.2017.1292363.
Article
CAS
PubMed
Google Scholar
Li C, Geng H, Ji L, Ma X, Yin Q, Xiong H. ESM-1: a novel tumor biomaker and its research advances. Anti Cancer Agents Med Chem. 2019;19(14):1687–94. https://doi.org/10.2174/1871520619666190705151542.
Article
CAS
Google Scholar
Tanriverdi T, Kemerdere R, Inal BB, Yuksel O, Emre HO, Ahmedov M, et al. Serum endocan levels before and after surgery on low-grade gliomas. Surg Neurol Int. 2017;8(1):32. https://doi.org/10.4103/sni.sni_405_16.
Article
PubMed
PubMed Central
Google Scholar
Laloglu E, Kumtepe Y, Aksoy H, Topdagi Yilmaz EP. Serum endocan levels in endometrial and ovarian cancers. J Clin Lab Anal. 2017;31(5):e22079. https://doi.org/10.1002/jcla.22079.
Article
CAS
Google Scholar
Rebollo J, Geliebter J, Reyes N. ESM-1 siRNA knockdown decreased migration and expression of CXCL3 in prostate cancer cells. Int J Biomed Sci. 2017;13(1):35.
PubMed
PubMed Central
Google Scholar
Lin L-Y, Yeh Y-C, Chu C-H, Won JG, Shyr Y-M, Chao Y, et al. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors. Medicine (Baltimore). 2017;96(41).
Sagara A, Igarashi K, Otsuka M, Kodama A, Yamashita M, Sugiura R, et al. Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Res Treat. 2017;161(2):269–78. https://doi.org/10.1007/s10549-016-4057-8.
Article
CAS
PubMed
Google Scholar
Huang X, Chen C, Wang X, Zhang J-Y, Ren B-H, Ma D-W, et al. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther. 2016;9:6297.
Article
Google Scholar
Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, et al. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep. 2016;6(1):32067. https://doi.org/10.1038/srep32067.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lv Z, Fan Y, Chen H, Zhao D. Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer. Tumor Biol. 2014;35(10):10497–502. https://doi.org/10.1007/s13277-014-2319-9.
Article
CAS
Google Scholar
El Behery MM, Seksaka MA, Ibrahiem MA, Saleh HS, El Alfy Y. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer. Arch Gynecol Obstet. 2013;288(6):1371–6. https://doi.org/10.1007/s00404-013-2863-3.
Article
CAS
PubMed
Google Scholar
Atukeren P, Kunbaz A, Turk O, Kemerdere R, Ulu MO, Turkmen Inanir N, et al. Expressions of endocan in patients with meningiomas and gliomas. Dis Markers. 2016;2016:1–5. https://doi.org/10.1155/2016/7157039.
Article
CAS
Google Scholar
Maurage C-A, Adam E, Minéo J-F, Sarrazin S, Debunne M, Siminski R-M, et al. Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol. 2009;68(6):633–41. https://doi.org/10.1097/NEN.0b013e3181a52a7f.
Article
CAS
PubMed
Google Scholar
Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010;56(2):180–7. https://doi.org/10.1111/j.1365-2559.2009.03458.x.
Article
PubMed
Google Scholar
Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomäki H, et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. J Pathol. 2012;228(3):378–90. https://doi.org/10.1002/path.4072.
Article
CAS
PubMed
Google Scholar
Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prévot V, et al. Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. Brain Pathol. 2012;22(6):757–64. https://doi.org/10.1111/j.1750-3639.2012.00578.x.
Article
CAS
PubMed
Google Scholar